Here is the abstract you requested from the imaps_2014 technical program page. This is the original abstract submitted by the author. Any changes to the technical content of the final manuscript published by IMAPS or the presentation that is given during the event is done by the author, not IMAPS.
|The Growing Role of More-than-Moore Technologies in Advanced Packaging|
|Keywords: Advanced Packaging, Moore's Law, 3D|
|Previously dismissed as being too exotic, thousands of new combinations of materials and technologies are being used to produce state-of-art MEMS, silicon photonics, novel transistors, sensors and other products proven to gain new benefits from integration of materials. Providing original methods and a significant advantage over traditional foundries -- that typically limit customers to working with no more than 20 elements from the periodic table – a new wave of nanotechnology development centers will be in a unique position to engage a world-leading 60 elements (more than half of the periodic table) in order to move novel ideas and breakthrough designs into development and production. Furthermore, today’s systems are more concerned than ever with SWaP-C (size, weight, power and cost) considerations. The miniaturization, electrical performance and level of integration of these complex systems cannot be supported solely by Moore’s Law. A 2.5D and 3D packaging platform is a disruptive, yet essential technology to solve the growing needs of many high-performance analog and mixed-signal applications. Companies in most industries cannot afford to chase Moore’s Law due to the high costs and high volume requirements. Those same companies are, however, benefitting from pursuing More-than-Moore (MtM) technologies that allow them to develop innovative products and achieve breakthrough results cost-effectively. By utilizing MtM fabs, customers use novel materials, unique back-end-of-line (BEOL) technologies and advanced 2.5D/3D packaging technologies to achieve unparalleled performance results at lower costs and much lower volume requirements. Not surprisingly, the Health Care / Life Sciences industry is one of the leaders in embracing the MtM technologies movement. Many of the companies who are building genome/DNA sequencing instrumentation and lab-on-a-chip devices are benefitting from advanced microfluidic & nanofluidic processes and 2.5D/3D integration technology. Nanofluidic devices have unique capabilities for manipulation and sensing of DNA molecules at the single-molecule level. MEMS devices are increasingly being used in ultrasound imaging equipment, smart pills, and various monitoring biosensors. Both in-vivo and in-vitro devices utilize MEMS, from microneedles to neurostimulators to drug delivery pumps. We can also provide a case study example of one of Novati’s customer’s. Such as, NanoMedical Systems, a small privately-held company developing a state-of-the-art nano-fluidics drug delivery technologies. We can also provide case studies for other markets like, telecom/datacom, aerospace & defense, consumer, etc.|
|Dave Anderson, CEO